Logo image of ALFLO.PA

FLORENTAISE SA (ALFLO.PA) Stock Fundamental Analysis

EPA:ALFLO - Euronext Paris - Matif - FR001400GO75 - Common Stock - Currency: EUR

2.36  -0.02 (-0.84%)

Fundamental Rating

1

Taking everything into account, ALFLO scores 1 out of 10 in our fundamental rating. ALFLO was compared to 63 industry peers in the Chemicals industry. ALFLO may be in some trouble as it scores bad on both profitability and health. ALFLO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALFLO had negative earnings in the past year.
ALFLO had a negative operating cash flow in the past year.
ALFLO had positive earnings in 4 of the past 5 years.
In multiple years ALFLO reported negative operating cash flow during the last 5 years.
ALFLO.PA Yearly Net Income VS EBIT VS OCF VS FCFALFLO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M 4M -4M -6M

1.2 Ratios

ALFLO has a Return On Assets of -0.21%. This is comparable to the rest of the industry: ALFLO outperforms 44.44% of its industry peers.
ALFLO has a Return On Equity (-0.68%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.21%
ROE -0.68%
ROIC N/A
ROA(3y)2.81%
ROA(5y)N/A
ROE(3y)13.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALFLO.PA Yearly ROA, ROE, ROICALFLO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 5 10 15 20

1.3 Margins

ALFLO's Profit Margin has declined in the last couple of years.
The Gross Margin of ALFLO (47.58%) is better than 66.67% of its industry peers.
ALFLO's Gross Margin has declined in the last couple of years.
ALFLO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-8.21%
PM growth 5YN/A
GM growth 3Y-3.86%
GM growth 5YN/A
ALFLO.PA Yearly Profit, Operating, Gross MarginsALFLO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 20 30 40 50

1

2. Health

2.1 Basic Checks

ALFLO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALFLO remains at a similar level compared to 1 year ago.
The debt/assets ratio for ALFLO has been reduced compared to a year ago.
ALFLO.PA Yearly Shares OutstandingALFLO.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALFLO.PA Yearly Total Debt VS Total AssetsALFLO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

ALFLO has an Altman-Z score of 0.63. This is a bad value and indicates that ALFLO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALFLO (0.63) is worse than 77.78% of its industry peers.
ALFLO has a Debt/Equity ratio of 0.59. This is a neutral value indicating ALFLO is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.59, ALFLO is doing worse than 65.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 0.63
ROIC/WACCN/A
WACC6.5%
ALFLO.PA Yearly LT Debt VS Equity VS FCFALFLO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.58 indicates that ALFLO may have some problems paying its short term obligations.
The Current ratio of ALFLO (0.58) is worse than 90.48% of its industry peers.
A Quick Ratio of 0.23 indicates that ALFLO may have some problems paying its short term obligations.
The Quick ratio of ALFLO (0.23) is worse than 92.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.23
ALFLO.PA Yearly Current Assets VS Current LiabilitesALFLO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 10M 20M 30M 40M

1

3. Growth

3.1 Past

The earnings per share for ALFLO have decreased strongly by -79.41% in the last year.
The Revenue for ALFLO has decreased by -13.68% in the past year. This is quite bad
ALFLO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.20% yearly.
EPS 1Y (TTM)-79.41%
EPS 3Y0%
EPS 5YN/A
EPS Q2Q%-54.1%
Revenue 1Y (TTM)-13.68%
Revenue growth 3Y7.2%
Revenue growth 5YN/A
Sales Q2Q%31.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALFLO.PA Yearly Revenue VS EstimatesALFLO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 20M 40M 60M
ALFLO.PA Yearly EPS VS EstimatesALFLO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

ALFLO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALFLO.PA Price Earnings VS Forward Price EarningsALFLO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

ALFLO's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.21
ALFLO.PA Per share dataALFLO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALFLO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FLORENTAISE SA

EPA:ALFLO (3/3/2025, 7:00:00 PM)

2.36

-0.02 (-0.84%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners92.45%
Ins Owner ChangeN/A
Market Cap19.47M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP10.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B 0.64
P/tB N/A
EV/EBITDA 11.21
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.87
FCFYN/A
OCF(TTM)-0.84
OCFYN/A
SpS7.06
BVpS3.7
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.21%
ROE -0.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.58%
FCFM N/A
ROA(3y)2.81%
ROA(5y)N/A
ROE(3y)13.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-8.21%
PM growth 5YN/A
GM growth 3Y-3.86%
GM growth 5YN/A
F-Score2
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA 3.22
Cap/Depr 128.95%
Cap/Sales 14.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.23
Altman-Z 0.63
F-Score2
WACC6.5%
ROIC/WACCN/A
Cap/Depr(3y)183.63%
Cap/Depr(5y)N/A
Cap/Sales(3y)14.94%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.41%
EPS 3Y0%
EPS 5YN/A
EPS Q2Q%-54.1%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.68%
Revenue growth 3Y7.2%
Revenue growth 5YN/A
Sales Q2Q%31.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-124.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y142.41%
OCF growth 3YN/A
OCF growth 5YN/A